Ozempic and Other GLP-1 Agonists May Cut Cancer Risk in Obese Patients, Study Finds
Discover how Ozempic and other GLP-1 agonists may reduce the risk of obesity-associated cancers in a recent study of obese patients. Learn more about the potential cancer-preventive effects of these diabetes medications.
Step Count or Time? New Study Suggests Both Equally Beneficial for Health
Discover how both step and time-based exercise goals equally reduce risks of early death and cardiovascular disease, according to a new study from Brigham and Women’s Hospital published in JAMA Internal Medicine. Learn more about the benefits of physical activity and how to choose the best goal for your health.